Back to front
Section

Business

Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.

FDA grants Priority Review to Johnson & Johnson’s RYBREVANT FASPRO™ sBLA for subcutaneous treatment in advanced head and neck cancer
The Apex Times

THE APEX TIMES

More Stories